Invention Application
US20110064736A1 TUMOR THERAPY WITH AN ANTIBODY FOR VASCULAR ENDOTHELIAL GROWTH FACTOR AND AN ANTIBODY FOR HUMAN EPITHELIAL GROWTH FACTOR RECEPTOR TYPE 2
审中-公开
肿瘤治疗与血管内皮生长因子和人类上皮生长因子受体2型抗体的抗体
- Patent Title: TUMOR THERAPY WITH AN ANTIBODY FOR VASCULAR ENDOTHELIAL GROWTH FACTOR AND AN ANTIBODY FOR HUMAN EPITHELIAL GROWTH FACTOR RECEPTOR TYPE 2
- Patent Title (中): 肿瘤治疗与血管内皮生长因子和人类上皮生长因子受体2型抗体的抗体
-
Application No.: US12947264Application Date: 2010-11-16
-
Publication No.: US20110064736A1Publication Date: 2011-03-17
- Inventor: Thomas Friess , Max Hasmann , Werner Scheuer
- Applicant: Thomas Friess , Max Hasmann , Werner Scheuer
- Priority: EP06111523.4 20060322; EP06021815.3 20061018
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61P35/00
Abstract:
The present invention provides a method of treating a breast cancer disease in a patient who has failed prior treatment with an anti-VEGF antibody, comprising administering to the patient a therapeutically effective amount of an anti-HER2 antibody while continuing said anti-VEGF antibody therapy. The invention also provides corresponding pharmaceutical kits and pharmaceutical compositions.
Public/Granted literature
Information query
